Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - OTHER FINANCING ACTIVITIES
Other Financing Activities URGN - UroGen Pharma Ltd.
19 M
LAST VALUE
274.64%
2 YEAR CAGR
39.51%
5 YEAR CAGR
15.98%
10 YEAR CAGR